CURAXIS PHARMACEUTICAL CORP Net Income
CURAXIS PHARMACEUTICAL CORP reported Net Income of -$339.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-14.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2012-05-14
- CURAXIS PHARMACEUTICAL CORP net income (loss) attributable to parent for the quarter ending 2012-03-31 was -$339.00K.
- CURAXIS PHARMACEUTICAL CORP net income (loss) attributable to parent for the quarter ending 2011-12-31 was $1.89M, a 35.15% increase year-over-year.
- CURAXIS PHARMACEUTICAL CORP net income (loss) attributable to parent for the quarter ending 2011-09-30 was $301.00K.
- CURAXIS PHARMACEUTICAL CORP net income (loss) attributable to parent for the quarter ending 2011-06-30 was -$284.00K.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 41 month | Net Income (Loss) Attributable to Parent 127 month | Net Income (Loss) Attributable to Parent 130 month | Net Income (Loss) Attributable to Parent 133 month |
|---|---|---|---|---|---|---|---|---|
| 2012-03-31 | -$339.00K 10-Q · filed 2012-05-14 | $1.55M derived: sum of 2 quarters · filed 2012-05-14 | $1.85M derived: sum of 3 quarters · filed 2012-05-14 | $1.57M derived: sum of 4 quarters · filed 2012-05-14 | -$88.80M 10-Q · filed 2012-05-14 | |||
| 2011-12-31 | $1.89M derived: 10-Q 12 month − 10-Q 9 month · filed 2012-05-14 | $2.19M derived: sum of 2 quarters · filed 2012-05-14 | $1.91M derived: sum of 3 quarters · filed 2012-05-14 | $1.33M 10-Q · filed 2012-05-14 | -$88.46M 10-K · filed 2012-03-29 | |||
| 2011-09-30 | $301.00K 10-Q · filed 2011-11-10 | $17.00K derived: sum of 2 quarters · filed 2011-11-10 | -$554.00K 10-Q · filed 2011-11-10 | $843.00K derived: sum of 4 quarters · filed 2012-05-14 | -$90.35M 10-Q · filed 2011-11-10 | |||
| 2011-06-30 | -$284.00K 10-Q · filed 2011-08-12 | -$855.00K 10-Q · filed 2011-08-12 | $542.00K derived: sum of 3 quarters · filed 2012-05-14 | -$2.24M derived: sum of 4 quarters · filed 2012-05-14 | -$90.65M 10-Q · filed 2011-08-12 | |||
| 2011-03-31 | -$571.00K 10-Q · filed 2012-05-14 | $826.00K derived: sum of 2 quarters · filed 2012-05-14 | -$1.96M derived: sum of 3 quarters · filed 2012-05-14 | -$2.44M derived: sum of 4 quarters · filed 2012-05-14 | ||||
| 2010-12-31 | $1.40M derived: 10-Q 12 month − 10-Q 9 month · filed 2012-05-14 | -$1.39M derived: sum of 2 quarters · filed 2012-05-14 | -$1.86M derived: sum of 3 quarters · filed 2012-05-14 | -$2.24M 10-Q · filed 2012-05-14 | ||||
| 2010-09-30 | -$2.79M 10-Q · filed 2011-11-10 | -$3.26M derived: sum of 2 quarters · filed 2011-11-10 | -$3.64M 10-Q · filed 2011-11-10 | |||||
| 2010-06-30 | -$475.00K 10-Q · filed 2011-08-12 | -$855.00M 10-Q · filed 2011-08-12 |